31st Annual E.G. Scott Microbiology Symposium
31st Annual E.G. Scott Microbiology Symposium
Release Date | August 7, 2024 |
Expiration Date | November 18, 2024 |
CME | 5.25 credits |
31st Annual E.G. Scott Microbiology Symposium (Hybrid Event)
Tuesday October 15, 2024
8:15am-3:00pm (Registration opens at 7:45am)
Live Option: ChristianaCare Ammon Center, Main Auditorium
Virtual Option: Zoom Videoconferencing
REGISTRATION DEADLINE: October 9, 2024 (no late in-person registrations will be accepted)
Pre-registration is required!
Please select the appropriate registration category and corresponding payment method for your desired attandance option.
The Zoom link & Conference information will be emailed 24/48 hours prior to the event.
Please check your spam & junk inbox if you do not see the email.
NOTE: Zoom link will NOT be sent if cost center information has not been received by the CC CME office.
$75.00 in-person registration fee
$65.00 virtual registration fee
**Cost Center transfers are for ChristianaCare employees only**
Questions: Contact Amy Minsker, CME Manager at amy.l.minsker@christianacare.org
Event Overview
Join us at the Annual E.G. Scott Microbiology Symposium. This symposium is designed as an update for microbiology technologists, laboratory directors, infectious disease physcians and other professional on the current issues in clinical microbiology. Topics covered will include: Microbiology Laboratory Stewardship, Antimicrobial Resistance, Sexually Transmitted Disease Testing Update, Weirdobacters (Case Studies of Unusual Bacteria) and Transplant-associated Viral Infections and Case Studies.
Target Audience
This activity is intended for specialty physicians, primary care physicians, microbiology technologists, pharmacists, physician assistants, nurse practitioners, and clinical laboratory scientists.
Statement of Need
There is a need to understand the landscape of mycobacterial testing methods. There are many tests that are expensive and overused: Review examples of improved value based care for patients using multiplex molecular panel diagnostic stewardship. There is a need to control costs in the laboratory: Provide examples of different modalities to accomplish diagnostic stewardship.
Educational Objectives
Upon completion of this activity learners should be able to:
- Define laboratory stewardship and the benefits to patients and laboratories
- Discuss tools for diagnostic stewardship that the attendee may consider implementing in their practice.
- Recognize the diagnostic devices that currently have FDA clearance for rapid antimicrobial susceptibility testing.
- Describe emerging technologies that are being developed to detect and characterize antimicrobial resistance.
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of Delaware and Christiana Care. The Medical Society of Delaware is accredited by the ACCME to provide continuing medical education for physicians.
It is the policy of the Medical Society of Delaware (MSD) to comply with the ACCME Standards for Commercial Support of Continuing Medical Education (CME). In keeping with these standards, all faculty participating in continuing medical education provided by MSD are expected to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations.
Joint providership of CME by MSD in no way implies endorsement of any product or service.
This activity is not supported by commercial funding.
Credit Designation Statement
The Medical Society of Delaware designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty and Disclosures
In accordance with the appropriate accrediting bodies, all planners, teachers, and authors with control over activity content are required to disclose to the provider any relevant financial relationships (those held by the planner or significant other, currently or within the last 24 months) with ineligible companies. Accredited providers are required to provide this information to learners before the start of an activity.
The following is a list of the faculty, along with any information they have disclosed regarding their relevant financial relationships.
Cynthia E. Flynn, MD (Planner, Activity Director) - has no relevant financial relationship(s) with ineligible companies to disclose.
Christine Burgert-Lon, DO (Planner) - has no relevant financial relationship(s) with ineligible companies to disclose.
Amy Minsker (Planner) - has no relevant financial relationship(s) with ineligible companies to disclose.
Julia Moeller MS, MLS(ASCP)CM (Planner, Moderator) - has no relevant financial relationship(s) with ineligible companies to disclose.
Lindsey Hardy MHA, MLS (ASCP) (Planner) - has no relevant financial relationship(s) with ineligible companies to disclose.
Daniel D. Rhoads, MD (Speaker) - on advisory board for Luminex/Diasorin & Seegene; received grant/research support from Abbott, Altona, BD, bioMerieux, Cepheid, Luminex, HelixBind, Hologic, Pattern Bio, Qiagen, Q-Linea, Roche, Specific Diagnostics, Cleveland Diagnostics, Selux Dx, Thermo Fisher, Vela Diagnostics; ownership interest (privately held) from Next Gen Diagonstics & Renascent Diagnostics - All of the relevant financial relationships listed for this individual have been mitigated.
Laurel Glaser, MD, PhD, D(ABMM) (Speaker) - has no relevant financial relationship(s) with ineligible companies to disclose.
Lars F. Westblade, PhD (Speaker) - on advisory board for Roche Molecular Systems, Shionogi, Talis Biomedical; received grant/research support from Accelerate Diagnostics, bioMerieux, Element Materials Technology, Hardy Diagnostics, Roche Molecular Systems, Selux Diagnostics - All of the relevant financial relationships listed for this individual have been mitigated.
Mondraya Howard, PhD, D(ABMM) (Speaker) - employed by Cepheid; received honorarium as speaker - All of the relevant financial relationships listed for this individual have been mitigated.
Joseph Yao, MD (Speaker) - received grant/research support from Abbott Molecular, Inc. Roche Molecular Systems, Inc. - All of the relevant financial relationships listed for this individual have been mitigated.
Disclaimer
All information contained within this activity is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained in this educational activity. No single reference or service can take the place of medical training, education and experience. This educational activity does not define a standard of care, nor is it intended to dictate an exclusive course of management. This information should not substitute for a visit or consultation with a health care provider.
Technical Requirements
This activity is best experienced using the most current browser of Firefox, Chrome, Safari, or Microsoft Edge. For all activities featuring audio you must have a sound card and speakers. To view graphic images and references that appear in separate "pop-up" windows, you must have JavaScript and session cookies enabled on your computer. Adobe Acrobat Reader may be required for certain activities.
Select the Continue button below to begin. You may return later if you are unable to complete the activity at this time.